Michel Kroes
Overview
Explore the profile of Michel Kroes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang S, Wei C, Aldworth C, George A, Kattlun J, Tomas G, et al.
Kidney360
. 2024 Oct;
PMID: 39437219
Background: Immunoglobulin A nephropathy (IgAN) is a chronic, progressive kidney disease in which proteinuria, reduced estimated glomerular filtration rate (eGFR), pain and fatigue are common. How symptoms interact and impact...
2.
Chaponda M, Aldhouse N, Kroes M, Wild L, Robinson C, Smith A
Int J STD AIDS
. 2018 Feb;
29(7):704-713.
PMID: 29393007
Psychiatric illness and sleeping disorders are important co-morbidities of human immunodeficiency virus (HIV) infection, which impact both the individual and antiretroviral therapy (ART) selection. This systematic review aimed to assess...
3.
Kroes M, Osei-Assibey G, Baker-Searle R, Huang J
Curr Med Res Opin
. 2015 Dec;
32(3):485-508.
PMID: 26652030
Objective: To review published evidence on the impact of weight/BMI change on health-related quality of life (HRQoL) in adults from the US with overweight/obesity. Methods: The systematic review was conducted...
4.
Larkin J, Paine A, Tumur I, Cappelleri J, Healey Sr P, Foley G, et al.
Expert Opin Pharmacother
. 2012 Dec;
14(1):27-39.
PMID: 23256638
Objectives: A systematic review/meta-analysis was conducted to assess the effectiveness and safety of second-line treatments for advanced renal cell carcinoma (RCC), which includes the vascular endothelial growth factor inhibitor axitinib....